ARCHIVES

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of May

May 31, 2013

Long-Term Estrogen Use May Increase Ovarian Cancer Risk

April 27, 2001

Imaging Technique Identifies Consequences Of Mutation

February 24, 2012

Y-90 Radioembolization Stabilizes Liver Metastases in 98.5 Percent Of Breast Cancer Patients in Study

March 28, 2014

In Brief: Des Exposed Women Face New Risk: Unfavorable Pregnancies; Hutchinson Labor Election Set

March 21, 1980

BRCA Status Can Guide Ovarian Cancer Treatment

April 25, 2008